Home / Business and Economy / FTC Settles Texas Anesthesiology Price-Fixing Case
FTC Settles Texas Anesthesiology Price-Fixing Case
23 Apr
Summary
- FTC settles with U.S. Anesthesia Partners over price-fixing allegations.
- The case involved over a dozen anesthesiology practices and 1,000 doctors.
- The settlement aims to restore a competitive market structure in Texas.
The U.S. Federal Trade Commission has reached a settlement with U.S. Anesthesia Partners (USAP), a company alleged to have orchestrated a significant private equity rollup. This rollup involved acquiring numerous anesthesiology practices across Texas, which regulators claim led to inflated prices for patient care.
The FTC initiated its lawsuit under the Biden administration, targeting industry consolidation by private equity firms. The case encompassed over a dozen anesthesiology practices, involving approximately 1,000 doctors and 750 nurses. The settlement's terms remain confidential for now, intended to aid further negotiations.
Despite initial claims against its creator, private equity firm Welsh, Carson, Anderson & Stowe, the firm settled with the FTC earlier. The current agreement seeks to re-establish a competitive market. If USAP fails to fully comply, the FTC reserves the right to resume its legal proceedings.
